alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 60, Number 82 (Friday, April 28, 1995)]
[Notices]
[Page 20989]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10482]



-----------------------------------------------------------------------

DEPARTMENT OF ENERGY
[Docket No. EL95-40-000 and Docket No. QF89-58-001]


Mega-Racine Associates, Inc.; Notice of Filing

April 24, 1995
    On April 21, 1995, Niagara Mohawk Power Corporation (Niagara 
Mohawk) filed a petition for a declaratory order revoking the 
qualifying status of a topping-cycle cogeneration facility owned by 
Megan-Racine Associates, Inc. in Canton, New York. The facility was 
granted certification as a qualifying cogeneration facility in an order 
dated January 27, 1989. Megan-Racine Associates, Inc., 46 FERC  
62,074, (1989). Niagara Mohawk claims in its petition that for the 
years 1991, 1992, 1993, and 1994 the facility did not meet the 
applicable operating and efficiency standards applicable to natural 
gas-fired, topping-cycle qualifying cogeneration facilities under 
section 292.205 of the Commission's regulations. 18 CFR 292.205. 
Niagara Mohawk asks the Commission to declare that the facility was not 
a qualifying facility for the years 1991, 1992, 1993, and 1994 and asks 
the Commission to revoked certification for the years 1991, 1992, 1993 
and 1994.
    Any person desiring to be heard or to protest said filing should 
file a motion to intervene or protest with the Federal Energy 
Regulatory Commission, 825 North Capitol Street, N.E., Washington, D.C. 
20426, in accordance with Rules 211 and 214 of the Commission's Rules 
of Practice and Procedure (18 CFR 285.211 and 385.214 (1992)). All such 
motions or protests should be filed on or before May 22, 1995. Protests 
will be considered by the Commission in determining the appropriate 
action to be taken, but will not serve to make protestants parties to 
the proceeding. Any person wishing to become a party must file a motion 
to intervene. Copies of this filing are on file with the Commission and 
are available for public inspection.
Lois D. Cashell,
Secretary.
[FR Doc. 95-10482 Filed 4-27-95; 8:45 am]
BILLING CODE 6717-01-M
Case 4:17-cv-00755-CW   Document 1-3   Filed 02/15/17   Page 1 of 2

Case 4:17-cv-00755-CW   Document 1-3   Filed 02/15/17   Page 2 of 2
[Federal Register Volume 60, Number 81 (Thursday, April 27, 1995)]
[Unknown Section]
[Page 20780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10317]



-----------------------------------------------------------------------


RAILROAD RETIREMENT BOARD

Public Hearing

    Notice is hereby given that the Railroad Retirement Board, acting 
through its designated Hearings Examiner, will hold a hearing on May 
22, 1995, 9:00 a.m., at the Board's meeting room on the 8th floor of 
its headquarters building, 844 North Rush Street, Chicago, Illinois, 
60611. The hearing will be held at the request of the CSX Intermodal 
for the purpose of taking evidence relating to status of their company 
under the Railroad Retirement and Railroad Unemployment Insurance Acts.
    The entire hearing will be open to the public. The person to 
contact for more information is Thomas W. Sadler, Assistant General 
Counsel (312) 751-4513, TDD (312) 751-4701.

    Dated: April 21, 1995.
Beatrice Ezerski,
Secretary to the Board.
[FR Doc. 95-10317 Filed 4-26-95; 8:45 am]
BILLING CODE 7905-01-M
In re Marcus REECE, petitioner.

No. 12-9148.

Supreme Court of the United States

April 1, 2013.

Petition for writ of habeas corpus denied.
Exhibit
      32.2




**CERTIFICATION
      PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
      SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of Pharma-Bio Serv, Inc. (the "Company")
      on
      Form 10-QSB for the period ending July 31, 2008 as filed with the Securities
      and
      Exchange Commission on the date hereof (the "Report"), Pedro J Lasanta, Chief
      Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as
      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
      my
      knowledge:





1.
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934, as amended; and





2.
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.





/s/
                Pedro J LasantaPedro
                J LasantaChief
                Financial Officer





September
      15, 2008
Postmarketing Surveillance 

of Generic Drugs

Once a generic medication is available for prescription or 

over-the-counter use, FDA continues to monitor its safety, 

efficacy, and quality.

After FDA approval, generic drug manufacturers 

must report any problems or serious adverse 

health effects to FDA for evaluation.

FDA periodically inspects manufacturing plants 

and continues to monitor drug quality.

Generic drug manufacturers will often propose 

changes to their products after they are 

approved; FDA evaluates these changes to 

ensure the drugs are still safe and effective. 

FDA monitors FAERS (the FDA Adverse Event 

Reporting System) and reviews MedWatch reports 

to investigate concerns related to generic drug 

product quality and therapeutic inequivalence.

Visit www.FDA.gov/GenericDrugs 

to learn more.
Keeping prepared foods longer than

7 days can make your customers sick!

Protect People Everywhere.

Serve or discard refrigerated,

prepared food within 7 days!

Copyright © International Association for Food Protection

Days at 41oF (5oC)
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.,

Chief Justice

Stephen J. Markman

Mary Beth Kelly

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

August 11, 2015 

# Order

August 11, 2015

1520 76 ( 5 0 )

PEOPLE OF THE STATE OF MICHIGAN

, Plaintiff

- Appell ee

,

v

CONNER CHANNING MCCOWAN

, Defendant

- Appell ant

. SC: 1520 76

COA: 3 19475

Ingham CC: 13

- 000363

- FC

________________________________________/

On order of the Chief Justice, the motion of defendant

- appellant for leave to file

an application for leave to appeal in excess of the page limit restriction is GRANT ED.

The 8 7

- page application submitted on July 3 0, 2015, is accepted for filing

.
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-21-00253-CV

J. L., Appellant

v.

Texas Department of Family and Protective Services, Appellee

FROM THE 22ND DISTRICT COURT OF COMAL COUNTY

NO. C2021-0494A, THE HONORABLE MELISSA MCCLENAHAN, JUDGE PRESIDING

M E M O R A N D U M O P I N I O N

In the above cause, appellant J.L. has filed a request for a de novo hearing from 

the associate judge’s finding of “aggravated circumstances” under section 262.2015(b)(3)(I) of 

the Texas Family Code. It appears that the request was mistakenly filed and docketed in this 

Court as a notice of appeal.1 A finding of aggravated circumstances in a parental-termination 

case is not a final order, and it does not fall within any of the categories of appealable 

interlocutory orders. See Hernandez v. Dep’t of Family & Protective Servs., 392 S.W.3d 188 

(Tex. App.–El Paso 2012, no pet.); see also Tex. Civ. Prac. & Rem. Code § 51.014. Accordingly,

we dismiss the appeal for want of jurisdiction.

1 This Court requested a response from appellant explaining how this Court may exercise 

jurisdiction over this appeal. As of the date of this order, no response has been received
2

__________________________________________

Gisela D. Triana, Justice

Before Justices Goodwin, Triana, and Kelly

Dismissed for Want of Jurisdiction

Filed: June 29, 2021
```
[Federal Register Volume 60, Number 86 (Thursday, May 4, 1995)]
[Notices]
[Page 22066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10995]

-----------------------------------------------------------------------

FEDERAL MARITIME COMMISSION

Ocean Freight Forwarder License Applicants

    Notice is hereby given that the following applicants have filed 
with the Federal Maritime Commission applications for licenses as ocean 
freight forwarders pursuant to section 19 of the Shipping Act of 1984 
(46 U.S.C. app. 1718 and 46 CFR Part 510).
    Persons knowing of any reason why any of the following applicants 
should not receive a license are requested to contact the Office of 
Freight Forwarders, Federal Maritime Commission, Washington, D.C. 
20573.

M & M Worldwide, Inc., 1940-44 N.W. 82 Ave., Miami, FL 33126, Officers: 
Mario A. Gomez, President; Maria S. Gomez, Vice President
D.L. Bynum & Company, Inc., 3040 Airfreight Road, Houston, TX 77032, 
Officer: Diana Lee Bynum, President
ProCargo Inc., 126 N. Langley Rd., Glen Burnie, MD 21060, Officer: 
Margaret B. Troy, President, Les Harrison, Director
Apollo Stevedoring Company, dba Jason Shipping Company, 13251 Eastern 
Ave--Port Manatee, Palmetto, FL 34221, Officers: Edward E. Sheffield, 
President; Joan E. Sheffield, Secretary
Worldwide Cargo Express Inc., dba Wessco International, 1551 N.W. 93rd 
Ave., Miami, FL 33172, Officers: Carlos A. Henao, President, Astrid 
Henao, Vice President
One Stop Cargo Services, Inc., 4410 NW 74th Ave., Miami, FL 33166, 
Officers: Ben Barbosa, President, Andreia Barbosa, Vice President.

    Dated: May 1, 1995.

    By the Federal Maritime Commission.
Joseph C. Polking,
Secretary.
[FR Doc. 95-10995 Filed 5-3-95; 8:45 am]
BILLING CODE 6730-01-M
```
Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the
-----------------------------------------------------------------------------
Sarbanes-Oxley Act of 2002
--------------------------

The undersigned, the Chief Executive Officer of The Wilber Corporation (the
"Company"), hereby certifies that to his knowledge on the date hereof:

      (a)   the  Form  10-Q of the  Company  for  the  nine-month  period  ended
            September 30, 2005, filed on the date hereof with the Securities and
            Exchange   Commission  (the  "Report"),   fully  complies  with  the
            requirements  of Section 13(a) or 15(d) of the  Securities  Exchange
            Act of 1934; and

      (b)   information contained in the Report fairly presents, in all material
            respects,  the financial  condition and results of operations of the
            Company as of and for the period covered by this report.


                            /s/ Alfred S. Whittet
                            ---------------------------------
                            Alfred S. Whittet
                            Vice Chairman, President and Chief Executive Officer
                            Date: November 8, 2005
                                  ----------------

The forgoing certification is being furnished solely pursuant to Subsections (a)
and  (b) of  Section  1350,  Chapter  63 of  Title  18,  United  States  Code in
accordance with Section 906 of the  Sarbanes-Oxley  Act of 2002 and shall not be
deemed  "filed" for  purposes of Section 18 of the  Securities  Exchange  Act of
1934, or otherwise  subject to the  liability of that section,  and shall not be
deemed to be  incorporated by reference into any filing under the Securities Act
of 1933 or the Securities Exchange Act of 1934.


                                       31
Stevon WARREN, petitioner, v. UNITED STATES.

No. 12-9849.

Supreme Court of the United States

May 28, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

MICHAEL MARTIN,

Plaintiff,

v.

BRISTOL-MYERS COMPANY, et al.,

Defendants.

Case No. 17-cv-00661-DMR 

SUA SPONTE JUDICIAL REFERRAL 

FOR PURPOSES OF DETERMINING 

RELATIONSHIP OF CASES

Re: Dkt. No. 1

On February 9, 2017, Defendants removed this action. Pursuant to Civil Local Rule 3-

12(c), the court sua sponte refers this case to Judge Jon S. Tigar to determine whether it is related 

to Williams et al. v. Bristol-Myers Squibb Co. et al., Case No. 3:16-cv-7152-JST.

IT IS SO ORDERED.

Dated: March 20, 2017

_____________________________________

Donna M. Ryu

United States Magistrate Judge

Case 3:17-cv-00661-JST Document 16 Filed 03/20/17 Page 1 of 1
[Federal Register Volume 60, Number 11 (Wednesday, January 18, 1995)]
[Notices]
[Page 3638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1098]



-----------------------------------------------------------------------

DEPARTMENT OF ENERGY
[Docket Nos. RP94-119-000, et al.]


Texas Gas Transmission Corp; Informal Settlement Conference

January 11, 1995.
    Take notice that an informal settlement conference will be convened 
in the above-captioned proceeding on January 18, 1995, at the offices 
of the Federal Energy Regulatory Commission, 810 First Street, NE., 
Washington, DC for the purpose of exploring the possible settlement of 
the above-referenced dockets.
    Any party, as defined by 18 CFR 385.102(c), or any participant as 
defined in 18 CFR 385.102(b), is invited to attend. Persons wishing to 
become a party must move to intervene and receive intervenor status 
pursuant to the Commission's regulations (18 CFR 385.214).
    For additional information please contact Michael D. Cotleur, (202) 
208-1076, or Russell B. Mamone, (202) 208-0744.
Lois D. Cashell,
Secretary.
[FR Doc. 95-1098 Filed 1-17-95; 8:45 am]
BILLING CODE 6717-01-M
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

JEANETTE BROWN,

Plaintiff,

v.

HTR PROPERTIES LLC,, et al.,

Defendants.

Case No. 17-cv-00829-WHO 

JUDGMENT

Judgment is hereby entered in accordance with the parties’ stipulation and Order thereon 

(Dkt. No. 97) and this Court’s Order granting in part plaintiff’s motion for attorney fees. Dkt. No. 

129. The Clerk shall close the case.

IT IS SO ORDERED.

Dated: February 4, 2020

William H. Orrick

United States District Judge
Ben Ray YODER, Appellant, v. STATE of Florida, Appellee.

Case No. 2D18-3654

District Court of Appeal of Florida, Second District.

Opinion filed May 24, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
女性と

鎮痛剤

女性は、男性とは違った痛みの体験

をします

• 女性は、男性よりも頻繁に痛みを体験

します。

• 片頭痛や腰痛など長期(慢性)の痛み

は、種類によって、女性に多く見られ

ます。

• 女性は、男性よりも早く処方鎮痛剤に

依存する可能性があります。

• 女性は男性よりも頻繁に処方鎮痛剤を

処方され、より高用量を投与され、よ

り長期間服用する可能性があります。

FDA 婦人保健部

www.fda.gov/womens

鎮痛剤の種類

市販(OTC)の医薬品

OTC鎮痛剤は、頭痛、風邪、生理痛などの多く

の症状用の一般的な薬に含まれています。OTC

鎮痛剤の種類は一般的に、アセトアミノフェン

と、アスピリンや低用量イブプロフェンなどの

NSAID(非ステロイド性抗炎症薬)に分けられ

ます。

処方薬

• 非オピオイド薬 – 痛みを和らげる処方

薬。非オピオイド処方鎮痛剤の種類には、ジ

クロフェナクとイブプロフェンが含まれま

す。イブプロフェンは市販薬として処方箋無

しでも購入できますが、医師は市販薬よりも

高い用量を処方することができます。

• オピオイド薬 – 手術後に服用したり、中

等度から重度の痛みを軽減するのに効果のあ

る鎮痛剤です。オピオイド系鎮痛剤の一般的

な処方薬は、オキシコドン、ヒドロコドン、

フェンタニル、そしてモルヒネ等がありま

す。

鎮痛剤は指示通りに服用すると、痛みを和らげ

る効果があります。しかし、これらの薬は誤っ

て服用または濫用した場合には、重い副作用を

引き起こしたり、死に至る可能性もあります。

中毒性のあるものも、あります。

鎮痛剤を安全に使用するためには、医療提供者

によく相談することが重要です。また、痛みを

和らげるための他のオプションがあるかどうか

についても、医療提供者にお尋ねください。

このファクトシートを参考にして、鎮痛剤を安

全に使う方法を医療提供者に問い合わせてくだ

さい。

市販(OTC)鎮痛剤も処方鎮痛剤も、それぞ

れに利点と、深刻な潜在的リスクがありま

す。
?

女性と鎮痛剤

このファクトシートは、FDA婦人保健部によって作成されました。

女性の健康に関する他の情報が欲しい方は、以下のURLをアクセスしてください。

www.fda.gov/womens

• 痛みを効果的に管理するためにオピオイド系

鎮痛剤を服用するべきか、他のオプションを

選択するべきかは、医療提供者に相談してく

ださい。オピオイドは、全ての人または全て

の種類の痛みに適しているわけではありませ

ん。

• あなたの痛みの状態を記録しましょう。痛み

を感じるとき、そしてそれがどのように感じ

るか、自分の体のどこが痛むかを、書き留め

ておいてください。メモは、医療提供者に見

せてください。

• 処方鎮痛剤を、他の人と共有しないでくださ

い。鎮痛剤はきっちり保管して、子供やペッ

トなどの手の届かないところに保管してくだ

さい。

• 鎮痛剤を、決められた期間以上に長期間服用

しないでください。自分が服用している薬に

ついての情報を入手してください。自分がそ

の薬を服用すべき期間を守ってください。他

の薬も服用している場合には、鎮痛剤を同時

に服用しても安全かどうかを医療提供者に確

認してください。

2021

鎮痛剤は誤用または濫用すると、重い副作用を引き起こしたり、死に至る可能

性があります。あなた自身とあなたの愛する人を守るために、薬の保管に十分

注意してください。

あなたの痛みについて医療提供

者に相談してください

オピオイドを服用す

る前に尋ねてくださ

い

鎮痛剤の服用指示に従って

ください

• 特定の鎮痛剤を服用しているときは、一緒にアル

コールを飲んだり、抗ヒスタミン薬やベンゾジア

ゼピンなどの薬を併用しないでください。アルコ

ールとさまざまな種類の鎮痛剤や他の薬を併用す

ると、呼吸が止まることがあります。

• 特定の薬や薬物への依存症、またはアルコール依

存症の場合は、医療提供者にそれを伝えてくださ

い。

• 使い残しの処方鎮痛剤は、処分してください。

使い残しの薬を処分する最良の方法について

は、FDAのWebサイトを確認するか、医療提供者

に問い合わせてください。

• あなたやあなたの愛する人が鎮痛剤中毒症の治療

を必要とする場合は、1-800-662-HELP (4357) 

に電話するか、https://findtreatment.samhsa.

gov/ をアクセスして情報を得てください。

女性と鎮痛剤 (JAPANESE)
# C_2018223EN.01000701.xml

| 27.6.2018 | EN | Official Journal of the European Union | C 223/7 |
| --- | --- | --- | --- |

27.6.2018

EN

Official Journal of the European Union

C 223/7

---

COUNCIL DECISION

of 22 June 2018

adopting the Council’s position on draft amending budget No 3 of the European Union for the financial year 2018

(2018/C 223/06)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 314 thereof, in conjunction with the Treaty establishing the European Atomic Energy Community, and in particular Article 106a thereof,

Having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002 (1) and in particular Article 41 thereof,

1

Whereas:

| — | the Union's budget for the financial year 2018 was definitively adopted on 30 November 2017 (2), |
| --- | --- |

—

the Union's budget for the financial year 2018 was definitively adopted on 30 November 2017 (2),

2

| — | on 23 May 2018, the Commission submitted a proposal containing draft amending budget No 3 to the general budget for the financial year 2018, |
| --- | --- |

—

on 23 May 2018, the Commission submitted a proposal containing draft amending budget No 3 to the general budget for the financial year 2018,

| — | so as to be able to cover funding needs related to the extension of the Facility for Refugees in Turkey and thus ensure continuity, draft amending budget No 3 to the general budget for 2018 needs to be adopted without delay. Therefore, it is justified to shorten, in accordance with Article 3(3) of the Council's Rules of Procedure, the eight-week period for the information of national Parliaments laid down in Article 4 of Protocol No 1, |
| --- | --- |

—

so as to be able to cover funding needs related to the extension of the Facility for Refugees in Turkey and thus ensure continuity, draft amending budget No 3 to the general budget for 2018 needs to be adopted without delay. Therefore, it is justified to shorten, in accordance with Article 3(3) of the Council's Rules of Procedure, the eight-week period for the information of national Parliaments laid down in Article 4 of Protocol No 1,

HAS DECIDED AS FOLLOWS:

Sole Article

The Council's position on draft amending budget No 3 of the European Union for the financial year 2018 was adopted on 22 June 2018.

The full text can be accessed for consultation or downloading on the Council's website: http://www.consilium.europa.eu/

Done at Luxembourg, 22 June 2018.

For the Council

The President

V. GORANOV

---

(1)  OJ L 298, 26.10.2012, p. 1.

1

(2)  OJ L 57, 28.2.2018, p. 1.

2

---
Daniel Nicholas BUCZKOWSKI, petitioner, v. UNITED STATES.

No. 12-9859.

Supreme Court of the United States

May 20, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
EMPIRE WORLD TOWERS, LLC, et al., petitioners, v. CDR CREANCES, S.A.S.

No. 12-1317.

Supreme Court of the United States

May 28, 2013.

Petition for writ of certiorari to the District Court of Appeal of Florida, Third District, denied.
Filed by Bowne Pure Compliance





Exhibit 10.3




AMENDMENT TO EMPLOYMENT AGREEMENT




This AMENDMENT TO EMPLOYMENT AGREEMENT (the “Amendment”), dated as of December 26, 2008,
amends that certain employment agreement, dated May 12, 2006 and as amended as of September 5, 2008
(the “Employment Agreement”), between CSS Industries, Inc., a Delaware corporation (“CSS”), and
Christopher J. Munyan (“Executive”).



WHEREAS, CSS and the Executive desire to amend the Employment Agreement so that it complies
with the requirements of section 409A of the Internal Revenue Code of 1986, as amended;



NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein and
for other good and valuable consideration, the receipt and sufficiency of which is acknowledged,
the parties hereto, intending to be legally bound, agree as follows:



1. Amendment and Restatement of the Last Sentence of the Second Paragraph of Section
4. The parties acknowledge and agree that the last sentence of the second paragraph of
Section 4 of the Employment Agreement shall be deleted in its entirety and replaced with the
following:




If you are eligible to receive the foregoing payment, such amount will be paid to you in
equal installments, with such installments being paid on the then-applicable paydays for CSS
executives over the designated period, commencing within sixty (60) days following your
termination date, unless delay is required as described in Section 10(b) herein.



2. Miscellaneous. Except as expressly modified hereby, the Employment Agreement
remains in full force and effect. Upon the execution and delivery hereof, the Employment Agreement
shall thereupon be deemed to be amended as hereinabove set forth, and this Amendment and the
Employment Agreement shall henceforth be read, taken and construed as one and the same instrument.
This Amendment may be executed in counterparts, each of which shall be considered an original
instrument, but all of which shall be considered one and the same agreement, and shall become
binding when one or more counterparts have been signed by each of the parties hereto and delivered
to the other party.



IN WITNESS WHEREOF, this Amendment has been executed by CSS and by the Executive as of the date
first above written.



	 	 	 	 	 
	 	CSS INDUSTRIES, INC. (“CSS”)

 	 
	 	By:  	/s/ Jack Farber
 	 
	 	 	Jack Farber 	 
	 	 	Chairman of the Board of Directors 	 
	 	 	 
	 	     /s/  Christopher J. Munyan
 	 
	 	Christopher J. Munyan (“Executive”) 	 
	 	 	 
	 



 


1
[Federal Register Volume 60, Number 84 (Tuesday, May 2, 1995)]
[Notices]
[Page 21512]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10679]



-----------------------------------------------------------------------


DEPARTMENT OF ENERGY
[Project No. 1927-008]


PacifiCorp; Notice of Staff Attendance at Project Tour

April 26, 1995.
    Staff from the Federal Energy Regulatory Commission, Office of 
Hydropower Licensing, Division of Project Review, will be attending a 
May 18, 1995, tour of the North Umpqua Hydroelectric Project. The tour 
will be conducted by Umpqua National Forest staff, and will begin at 
9:00 am at the Umpqua National Forest Supervisor's Office in Roseburg, 
Oregon. Those wishing to participate in the tour should contact Jim 
Wieman, Umpqua National Forest, at (503) 942-5591.
Lois D. Cashell,
Secretary.
[FR Doc. 95-10679 Filed 5-1-95; 8:45 am]
BILLING CODE 6717-01-M